M.D. Anderson Cancer Center: clinical-trial pipeline
M.D. Anderson Cancer Center is the sponsor of 3,044 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 1,065 are not yet finished and 20 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials1,065
Phase 2/3 and 3133
Countries34
New in 90 days20
Trials by phase
| Phase | Trials |
|---|---|
| Phase 2 | 1,036 |
| Not applicable | 1,004 |
| Phase 1 | 485 |
| Phase 1/2 | 284 |
| Phase 3 | 103 |
| Early phase 1 | 72 |
| Phase 2/3 | 30 |
| Phase 4 | 30 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 1,237 |
| Recruiting | 510 |
| Active, not recruiting | 491 |
| Terminated | 416 |
| Withdrawn or not authorised | 227 |
| Unknown | 77 |
| Not yet recruiting | 64 |
| Suspended or halted | 22 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 2,706 |
| Nephrology and urology | 239 |
| Rare and genetic diseases | 223 |
| Gastroenterology and liver | 218 |
| Women's health and obstetrics | 180 |
| Haematology | 135 |
| Metabolic and endocrine (diabetes, obesity) | 105 |
| Infectious disease and vaccines | 93 |
| Musculoskeletal | 71 |
| Immunology and rheumatology | 55 |
| Cardiovascular | 53 |
| Respiratory | 40 |
Countries
| Country | Trials |
|---|---|
| United States | 2,869 |
| Canada | 11 |
| Brazil | 6 |
| China | 5 |
| Israel | 4 |
| Mexico | 4 |
| Colombia | 3 |
| Spain | 3 |
| Italy | 3 |
| Peru | 3 |
| Argentina | 2 |
| Australia | 2 |
| Chile | 2 |
| France | 2 |
| Japan | 2 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-16 | New trial posted | Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Im… |
| 2026-10-15 | New trial posted | PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In A… |
| 2026-10-13 | New trial posted | Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Under… |
| 2026-10-13 | New trial posted | Food Is Medicine In Survivorship (Foodiis-AYA): Examining The Feasibility And Acceptabili… |
| 2026-10-05 | New trial posted | Prospective Study To Assess The Outcomes Of Nitrous Oxide Cryoablation For Treatment Of D… |
| 2026-10-05 | New trial posted | 2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute Lym… |
| 2026-10-05 | New trial posted | A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy |
| 2026-10-02 | New trial posted | Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bi… |
| 2026-10-01 | New trial posted | Supporting Families In Coping With Parental Cancer: A Multi-Site Randomized Controlled Tr… |
| 2026-10-01 | New trial posted | Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment… |
| 2026-10-01 | New trial posted | Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Che… |
| 2026-09-28 | New trial posted | A Phase 1/2 Trial Of Larotrectinib And Pembrolizumab In Patients With Solid Tumors Previo… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05023967 | Metformin and Nightly Fasting in Women With Early Breast Cancer | Phase 2 | Active, not recruiting | Italy, United States |
| NCT01880567 | Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patien… | Phase 2 | Active, not recruiting | United States |
| NCT00618553 | Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting | Phase 2 | Active, not recruiting | United States |
| NCT04783168 | Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study | Not applicable | Recruiting | United States |
| NCT07137481 | Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphode… | Phase 2 | Not yet recruiting | United States |
| NCT03819985 | Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectabl… | Phase 2 | Active, not recruiting | United States |
| NCT07224152 | NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer | Phase 1/2 | Recruiting | United States |
| NCT06545682 | Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) | Phase 1 | Recruiting | United States |
| NCT04447222 | Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors | Not applicable | Active, not recruiting | United States |
| NCT03367156 | Dexamethasone in Controlling Dyspnea in Patients With Cancer | Phase 2 | Active, not recruiting | United States |
| NCT02446457 | Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lympho… | Phase 2 | Active, not recruiting | United States |
| NCT01245712 | Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer | Phase 2 | Active, not recruiting | United States |
| NCT07852949 | Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patie… | Not applicable | Not yet recruiting | United States |
| NCT05132296 | Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer | Not applicable | Active, not recruiting | United States |
| NCT03888651 | Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Pati… | Not applicable | Active, not recruiting | United States |
| NCT03048279 | Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2 | Not applicable | Active, not recruiting | United States |
| NCT07136077 | A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Canc… | Phase 2 | Active, not recruiting | United States |
| NCT05239403 | Association Between Gut Microbiome and Dietary Determinants and Vaccine Response | Not applicable | Active, not recruiting | United States |
| NCT07415018 | Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease | Not applicable | Recruiting | United States |
| NCT06409052 | Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women | Not applicable | Recruiting | United States |
| NCT01512589 | Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial | Phase 2 | Active, not recruiting | United States |
| NCT03175432 | Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain M… | Phase 2 | Active, not recruiting | United States |
| NCT01788787 | Ask Advise Connect (AAC) Harris Heath CPRIT | Not applicable | Active, not recruiting | United States |
| NCT06377527 | Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA) | Not applicable | Recruiting | United States |
| NCT01439659 | Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer | Phase 2 | Active, not recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "M.D. Anderson Cancer Center clinical trials: 1,065 open, 133 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/m-d-anderson-cancer-center/, data as of 2026-10-25.